Align Technology (ALGN) Q1 2026 earnings review
Solid Start to 2026 Muted by Cautious Macro & Middle East Outlook
Align Technology delivered a strong Q1 2026, beating expectations with record Clear Aligner volume of 685.7k cases (+6.7% YoY) and total revenue of $1,040.1M (+6.2% YoY). The growth was fueled by double-digit expansion across EMEA, APAC, and LATAM, alongside stability in North America. However, the top-line beat is overshadowed by a cautious Q2 guidance that bakes in expected patient traffic headwinds from the ongoing conflict in the Middle East. Additionally, the Systems and Services segment (iTero scanners) stalled at just 0.9% YoY growth due to a mix shift toward lower-priced and leased configurations.
🐂 Bull Case
Double-digit volume growth in EMEA, APAC, and LATAM proves Align's geographic expansion strategy is working. DSOs continue to act as a force multiplier globally.
Non-GAAP operating margin came in at a healthy 21.5%. Management reaffirmed FY26 guidance for an ~400 bps GAAP operating margin improvement, showing strict cost discipline.
🐻 Bear Case
Scanner revenue grew an anemic 0.9% YoY and dropped 12.1% sequentially. A shift toward lower-priced PC-based configurations and leasing options is capping top-line growth here.
Management explicitly flagged the Middle East conflict as a drag on Q2 patient traffic and consumer demand, introducing a new layer of macroeconomic unpredictability.
⚖️ Verdict: ⚪
Neutral. Align is executing well on what it can control—clear aligner volumes and operational efficiency—but external macro factors and capital equipment pricing shifts limit near-term upside.
Key Themes
International Markets Powering the Top Line
EMEA, APAC, and LATAM all delivered double-digit volume growth. The continued international momentum, supported by localized strategies, is actively offsetting the sluggish recovery in the North American retail doctor channel. Total Clear Aligner volume grew 6.7% YoY, a stable performance relative to the 7.7% seen in the prior quarter.
Middle East Conflict Dragging Q2 Outlook
A new macroeconomic concern has materialized: management explicitly noted that the ongoing military action in the Middle East is impacting patient traffic and case conversions. They have taken a 'prudent approach' to Q2 guidance to account for softer aligner and scanner demand across the EMEA region, noting that broader escalation could worsen consumer sentiment.
Systems & Services Revenue Mix Shift
Despite the continued rollout of the innovative iTero Lumina ecosystem, Systems and Services revenue was up just 0.9% YoY ($184.1M). Management cited a mix shift toward lower-priced scanner offerings, including PC-based configurations, leasing, and rental units. This structural shift in how doctors acquire capital equipment may permanently pressure revenue growth in this segment.
Broad Segment Penetration: Teens, Adults, and GPs
Align continues to drive adoption across all patient and practitioner types. In Q1, adult patients increased 7.8% YoY while teen/kid patients grew 4.8% YoY. Furthermore, volumes shipped to Orthodontists rose 7.4% while GP Dentist volumes rose 5.6%, showing that the 'scan every patient' mantra and digital dentistry platforms are driving cross-channel stickiness.
Navigating Tariff Fluctuations
The Supreme Court recently struck down the IEEPA tariffs, but they were immediately replaced by temporary Section 122 tariffs. Despite this regulatory volatility, Align stated it does not expect a material impact on its results, reinforcing the resilience of its global manufacturing footprint (Mexico, China, Poland, Israel).
Other KPIs
Stable YoY (up slightly from 13.4% in 25Q1). FX created a 0.1 point headwind. Non-GAAP operating margin expanded significantly to 21.5%, up 240 basis points from 19.1% in the prior year period, showing the company is successfully extracting operational leverage despite the top-line macro headwinds.
Accelerating dramatically compared to $52.7 million in Q1 2025. This robust cash generation supported the completion of a $200 million stock repurchase program during the quarter, with another $200 million tranche slated to begin around May 1, 2026.
Guidance
Decelerating sequentially on a growth basis. The midpoint ($1,050M) implies ~4% YoY growth, a step down from the 6.2% achieved in Q1, directly reflecting the prudent stance taken regarding Middle East geopolitical disruptions.
Stable. Management reaffirmed full-year guidance, anticipating that FX tailwinds (expected to add ~100 bps for the year) will moderate in the remaining quarters.
Accelerating compared to the 21.5% printed in Q1. The company remains committed to its structural profitability initiatives, including the massive restructuring efforts undertaken in late 2025, to deliver this 100 bps YoY improvement for the full year.
Accelerating vs the -12.1% sequential drop in Q1. Rebound expected as typical Q1 capital equipment seasonality fades, though the mix shift toward leasing and lower-priced PC units remains a structural drag.
Key Questions
Middle East Impact Quantification
Can you quantify the expected revenue or volume drag in Q2 specifically attributed to the Middle East conflict, and are you seeing this impact isolated to MEA or bleeding into broader European consumer sentiment?
Capital Equipment Strategy
With the mix shift toward PC-based scanner configurations and leasing, how does this alter the long-term margin profile and lifetime value of the Systems & Services segment compared to traditional full-system hardware sales?
Teen Season Preparedness
Given the mixed macroeconomic signals, how is the promotional strategy shifting ahead of the critical Q2/Q3 teen season to ensure conversion rates improve over last year's sluggish performance?